Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Dutogliptin; Drug: Sitagliptin
Sponsors: Forest Laboratories; Phenomix
Enrolling by invitation - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: AZD1656; Drug: Pioglitazone
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: ASP1941; Drug: pioglitazone hydrochloride
Sponsor: Astellas Pharma Inc
Completed - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: pioglitazone/rosiglitazone/placebo; Drug: rosiglitazone/pioglitazone/placebo; Drug: placebo/pioglitazone/rosiglitazone; Drug: pioglitazone/placebo/rosiglitazone; Drug: rosiglitazone/placebo/pioglitazone; Drug: placebo/rosiglitazone/pioglitazone
Sponsor: Solvay Pharmaceuticals
Completed - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate; Drug: Comparator: placebo to pioglitazone; Drug: Comparator: placebo to sitagliptin; Drug: Comparator: pioglitazone; Drug: Comparator: glimepiride or gliclazide; Drug: Comparator: metformin; Drug: Comparator: pioglitazone rescue therapy
Sponsor: Merck
Not yet recruiting - verified February 2010